Diacylglycerol kinase β knockout mice exhibit lithiumsensitive behavioral abnormalities

PLoS ONE

Volumn 5, Issue 10, 2010, Pages

  Kakefuda, Kenichi ^a   Oyagi, Atsushi ^a   Ishisaka, Mitsue ^a   Tsuruma, Kazuhiro ^a   Shimazawa, Masamitsu ^a   Yokota, Koichi ^b   Shirai, Yasuhito ^c   Horie, Kyoji ^d   Saito, Naoaki ^c   Takeda, Junji ^d   Hara, Hideaki ^a  

^a GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

^b 1 5 5 Minatojima Minamimachi   (Japan)

^c KOBE UNIVERSITY   (Japan)

^d OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DIACYLGLYCEROL KINASE; DIACYLGLYCEROL KINASE BETA; DIAZEPAM; GLYCOGEN SYNTHASE KINASE 3BETA; HALOPERIDOL; IMIPRAMINE; LITHIUM CHLORIDE; PROTEIN KINASE B; UNCLASSIFIED DRUG; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA; LITHIUM DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY DISORDER; ARTICLE; BEHAVIOR DISORDER; CONTROLLED STUDY; DEPRESSION; DRUG SENSITIVITY; HYPERACTIVITY; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; PSYCHOMOTOR DISORDER; SIGNAL TRANSDUCTION; ANIMAL; ANIMAL BEHAVIOR; DRUG EFFECT; GENETICS; MAZE TEST; METABOLISM; MOUSE MUTANT; PHOSPHORYLATION; PSYCHOMOTOR PERFORMANCE; WESTERN BLOTTING;

MUS;

ANIMALS; BEHAVIOR, ANIMAL; BLOTTING, WESTERN; DIACYLGLYCEROL KINASE; GLYCOGEN SYNTHASE KINASE 3; LITHIUM COMPOUNDS; MAZE LEARNING; MICE; MICE, KNOCKOUT; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; PSYCHOMOTOR PERFORMANCE;

EID: 78149448880     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0013447     Document Type: Article

References (40)

1. Kanoh H, Yamada K, Sakane F (2002) Diacylglycerol kinases: emerging downstream regulators in cell signaling systems. J Biochem 131: 629-633.
2. Merida I, Avila-Flores A, Merino E (2008) Diacylglycerol kinases: at the hub of cell signalling. Biochem J 409: 1-18.
3. Topham MK, Prescott SM (1999) Mammalian diacylglycerol kinases, a family of lipid kinases with signaling functions. J Biol Chem 274: 11447-11450.
4. van Blitterswijk WJ, Houssa B (2000) Properties and functions of diacylglycerol kinases. Cell Signal 12: 595-605.
5. Goto K, Kondo H (1993) Molecular cloning and expression of a 90-kDa diacylglycerol kinase that predominantly localizes in neurons. Proc Natl Acad Sci U S A 90: 7598-7602.
6. Adachi N, Oyasu M, Taniguchi T, Yamaguchi Y, Takenaka R, et al. (2005) Immunocytochemical localization of a neuron-specific diacylglycerol kinase beta and gamma in the developing rat brain. Brain Res Mol Brain Res 139: 288-299.
7. Hozumi Y, Watanabe M, Otani K, Goto K (2009) Diacylglycerol kinase beta promotes dendritic outgrowth and spine maturation in developing hippocampal neurons. BMC Neurosci 10: 99.
8. Shirai Y, Kouzuki T, Kakefuda K, Moriguchi S, Oyagi A, et al. (2010) Essential role of neuron-enriched diacylglycerol kinase (DGK), DGKbeta in neurite spine formation, contributing to cognitive function. PLoS One 5: e11602.
9. Caricasole A, Bettini E, Sala C, Roncarati R, Kobayashi N, et al. (2002) Molecular cloning and characterization of the human diacylglycerol kinase beta (DGKbeta) gene: alternative splicing generates DGKbeta isotypes with different properties. J Biol Chem 277: 4790-4796.
10. Baum AE, Akula N, Cabanero M, Cardona I, Corona W, et al. (2008) A genome-wide association study implicates diacylglycerol kinase eta (DGKH) and several other genes in the etiology of bipolar disorder. Mol Psychiatry 13: 197-207.
11. Schulze TG, Detera-Wadleigh SD, Akula N, Gupta A, Kassem L, et al. (2009) Two variants in Ankyrin 3 (ANK3) are independent genetic risk factors for bipolar disorder. Mol Psychiatry 14: 487-491.
12. Horie K, Yusa K, Yae K, Odajima J, Fischer SE, et al. (2003) Characterization of Sleeping Beauty transposition and its application to genetic screening in mice. Mol Cell Biol 23: 9189-9207.
13. Keng VW, Yae K, Hayakawa T, Mizuno S, Uno Y, et al. (2005) Region-specific saturation germline mutagenesis in mice using the Sleeping Beauty transposon system. Nat Methods 2: 763-769.
14. Roybal K, Theobold D, Graham A, DiNieri JA, Russo SJ, et al. (2007) Mania-like behavior induced by disruption of CLOCK. Proc Natl Acad Sci U S A 104: 6406-6411.
15. Gelenberg AJ, Kane JM, Keller MB, Lavori P, Rosenbaum JF, et al. (1989) Comparison of standard and low serum levels of lithium for maintenance treatment of bipolar disorder. N Engl J Med 321: 1489-1493.
16. Beaulieu JM, Sotnikova TD, Yao WD, Kockeritz L, Woodgett JR, et al. (2004) Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/ glycogen synthase kinase 3 signaling cascade. Proc Natl Acad Sci U S A 101: 5099-5104.
17. Quiroz JA, Gould TD, Manji HK (2004) Molecular effects of lithium. Mol Interv 4: 259-272.
18. McClung CA, Sidiropoulou K, Vitaterna M, Takahashi JS, White FJ, et al. (2005) Regulation of dopaminergic transmission and cocaine reward by the Clock gene. Proc Natl Acad Sci U S A 102: 9377-9381.
19. Miyakawa T, Leiter LM, Gerber DJ, Gainetdinov RR, Sotnikova TD, et al. (2003) Conditional calcineurin knockout mice exhibit multiple abnormal behaviors related to schizophrenia. Proc Natl Acad Sci U S A 100: 8987-8992.
20. Oyagi A, Oida Y, Kakefuda K, Shimazawa M, Shioda N, et al. (2009) Generation and characterization of conditional heparin-binding EGF-like growth factor knockout mice. PLoS One 4: e7461.
21. Phiel CJ, Wilson CA, Lee VM, Klein PS (2003) GSK-3alpha regulates production of Alzheimer's disease amyloid-beta peptides. Nature 423: 435-439.
22. Corne SJ, Pickering RW (1967) A possible correlation between drug-induced hallucinations in man and a behavioural response in mice. Psychopharmacologia 11: 65-78.
23. Verebey K, Kogan MJ, Mule SJ (1981) Phencyclidine-induced stereotype in rats: effects of methadone, apomorphine, and naloxone. Psychopharmacology (Berl) 75: 44-47.
24. Jenkins GH, Fisette PL, Anderson RA (1994) Type I phosphatidylinositol 4-phosphate 5-kinase isoforms are specifically stimulated by phosphatidic acid. J Biol Chem 269: 11547-11554.
25. Liu CH, Machado FS, Guo R, Nichols KE, Burks AW, et al. (2007) Diacylglycerol kinase zeta regulates microbial recognition and host resistance to Toxoplasma gondii. J Exp Med 204: 781-792.
26. Cross DA, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA (1995) Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378: 785-789.
27. Frame S, Cohen P, Biondi RM (2001) A common phosphate binding site explains the unique substrate specificity of GSK3 and its inactivation by phosphorylation. Mol Cell 7: 1321-1327.
28. Chalecka-Franaszek E, Chuang DM (1999) Lithium activates the serine/threonine kinase Akt-1 and suppresses glutamate-induced inhibition of Akt-1 activity in neurons. Proc Natl Acad Sci U S A 96: 8745-8750.
29. De Sarno P, Li X, Jope RS (2002) Regulation of Akt and glycogen synthase kinase-3 beta phosphorylation by sodium valproate and lithium. Neurophar-macology 43: 1158-1164.
30. Jope RS (2003) Lithium and GSK-3: one inhibitor, two inhibitory actions, multiple outcomes. Trends Pharmacol Sci 24: 441-443.
31. Zhang F, Phiel CJ, Spece L, Gurvich N, Klein PS (2003) Inhibitory phosphorylation of glycogen synthase kinase-3 (GSK-3) in response to lithium. Evidence for autoregulation of GSK-3. J Biol Chem 278: 33067-33077.
32. Prickaerts J, Moechars D, Cryns K, Lenaerts I, van Craenendonck H, et al. (2006) Transgenic mice overexpressing glycogen synthase kinase 3beta: a putative model of hyperactivity and mania. J Neurosci 26: 9022-9029.
33. Gould TD, Einat H, O'Donnell KC, Picchini AM, Schloesser RJ, et al. (2007) Beta-catenin overexpression in the mouse brain phenocopies lithium-sensitive behaviors. Neuropsychopharmacology 32: 2173-2183.
34. Beaulieu JM, Marion S, Rodriguiz RM, Medvedev IO, Sotnikova TD, et al. (2008) A beta-arrestin 2 signaling complex mediates lithium action on behavior. Cell 132: 125-136.
35. Liu F, Liang Z, Shi J, Yin D, El-Akkad E, et al. (2006) PKA modulates GSK- 3beta- and cdk5-catalyzed phosphorylation of tau in site- and kinase-specific manners. FEBS Lett 580: 6269-6274.
36. Kimura T, Yamashita S, Nakao S, Park JM, Murayama M, et al. (2008) GSK- 3beta is required for memory reconsolidation in adult brain. PLoS One 3: e3540.
37. Bennett AOM (2008) Stress and anxiety in schizophrenia and depression: glucocorticoids, corticotropin-releasing hormone and synapse regression. Aust N Z J Psychiatry 42: 995-1002.
38. Shansky RM, Hamo C, Hof PR, McEwen BS, Morrison JH (2009) Stressinduced dendritic remodeling in the prefrontal cortex is circuit specific. Cereb Cortex 19: 2479-2484.
39. Pierri JN, Volk CL, Auh S, Sampson A, Lewis DA (2001) Decreased somal size of deep layer 3 pyramidal neurons in the prefrontal cortex of subjects with schizophrenia. Arch Gen Psychiatry 58: 466-473.
40. Rosoklija G, Toomayan G, Ellis SP, Keilp J, Mann JJ, et al. (2000) Structural abnormalities of subicular dendrites in subjects with schizophrenia and mood disorders: preliminary findings. Arch Gen Psychiatry 57: 349-356.